GR3003747T3 - - Google Patents

Info

Publication number
GR3003747T3
GR3003747T3 GR920400170T GR920400170T GR3003747T3 GR 3003747 T3 GR3003747 T3 GR 3003747T3 GR 920400170 T GR920400170 T GR 920400170T GR 920400170 T GR920400170 T GR 920400170T GR 3003747 T3 GR3003747 T3 GR 3003747T3
Authority
GR
Greece
Prior art keywords
per molecule
effective amount
iodine
silicon per
diorganopolysiloxane
Prior art date
Application number
GR920400170T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3003747T3 publication Critical patent/GR3003747T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G1/00—Preparation of wine or sparkling wine
    • C12G1/06—Preparation of sparkling wine; Impregnation of wine with carbon dioxide
    • C12G1/064—Preparation of sparkling wine; Impregnation of wine with carbon dioxide using enclosed yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/16—Halogen-containing compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • C08K5/098—Metal salts of carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • Silicon Polymers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Water Treatments (AREA)
  • Water Treatment By Sorption (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Removal Of Specific Substances (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
GR920400170T 1987-02-26 1992-02-07 GR3003747T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8702882A FR2611733B1 (fr) 1987-02-26 1987-02-26 Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux

Publications (1)

Publication Number Publication Date
GR3003747T3 true GR3003747T3 (el) 1993-03-16

Family

ID=9348558

Family Applications (2)

Application Number Title Priority Date Filing Date
GR920400170T GR3003747T3 (el) 1987-02-26 1992-02-07
GR920400169T GR3003746T3 (el) 1987-02-26 1992-02-07

Family Applications After (1)

Application Number Title Priority Date Filing Date
GR920400169T GR3003746T3 (el) 1987-02-26 1992-02-07

Country Status (12)

Country Link
US (1) US4886661A (el)
EP (2) EP0285525B1 (el)
JP (2) JPS63243164A (el)
AT (2) ATE71646T1 (el)
AU (2) AU601262B2 (el)
BR (2) BR8800801A (el)
CA (2) CA1308836C (el)
DE (2) DE3867509D1 (el)
ES (2) ES2027784T3 (el)
FR (1) FR2611733B1 (el)
GR (2) GR3003747T3 (el)
ZA (2) ZA881328B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019970A (en) * 1985-07-31 2000-02-01 Ghent William R. Treatment of iodine deficiency diseases
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
FR2611735B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition elastomere silicone polyaddition contenant de l'iode pour le traitement de l'eau
FR2611734B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition elastomere silicone polycondensation contenant de l'iode pour le traitement des eaux
FR2611733B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
FR2634772A1 (fr) * 1988-07-29 1990-02-02 Rhone Poulenc Chimie Composition a base d'huile diorganopolysiloxane contenant de l'iode pour le traitement des eaux
FR2648143B1 (fr) * 1989-06-08 1991-09-06 Rhone Poulenc Chimie Composition comprenant un copolymere silicone thermoplastique et un compose de l'iode, utilisable apres sa mise en forme, pour le traitement des eaux
US5910318A (en) * 1991-03-28 1999-06-08 943038 Ontario Inc. Treatment of iodine deficiency diseases
US5955101A (en) * 1991-03-28 1999-09-21 943038 Ontario Inc. Dry starch-iodine pharmaceutical formulations
CN1055393C (zh) * 1996-06-13 2000-08-16 中国人民解放军59174部队 饮水缓释补碘剂
DE10109484A1 (de) * 2001-02-28 2002-09-12 Degussa Oberflächenmodifizierte, dotierte, pyrogen hergestellte Oxide
HUP1000362A2 (en) 2010-07-12 2012-11-28 Egis Gyogyszergyar Nyrt Antiseptic and disinfecting compositions having reduced iodine content
US8784274B1 (en) 2011-03-18 2014-07-22 Thomas C. Chuang Athletic performance monitoring with body synchronization analysis

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798023A (en) * 1957-07-02 zapapas etal
US2918400A (en) * 1956-04-16 1959-12-22 Chilean Nitrate Sales Corp Sanitizing compositions
NL124343C (el) * 1964-06-05
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
US3992518A (en) * 1974-10-24 1976-11-16 G. D. Searle & Co. Method for making a microsealed delivery device
US4010259A (en) * 1975-07-17 1977-03-01 Johansson J A Olof Disinfectants containing iodine complexed to a hydrophilic organic carrier
US4107346A (en) * 1976-09-02 1978-08-15 Kravitz Hilard L Dietary salt compositions
DE2642032C2 (de) * 1976-09-18 1987-04-30 Rupprecht, Herbert, Prof. Dr., 8400 Regensburg Verfahren zur Inkorporierung von Wirkstoffen in siliciumdioxidhaltige Trägermaterialien und eine siliciumdioxidhaltige Zubereitung
JPS5434362A (en) * 1977-08-24 1979-03-13 Shin Etsu Chem Co Ltd Curable organopolysiloxane composition
US4275194A (en) * 1977-11-26 1981-06-23 Nihon Tennen Gas Kogyo Co., Ltd. Chitosan-iodine adduct
US4384960A (en) * 1979-11-13 1983-05-24 Polley R D Iodine dispenser and method of dispensing iodine
US4500337A (en) * 1980-09-03 1985-02-19 Young Robert W Adherent controlled release microbiocides containing hydrolyzable silanes and organic titanium compounds
US4420590A (en) * 1981-04-06 1983-12-13 Halex, Inc. Bacteriocidal resins and disinfection of water therewith
US4559054A (en) * 1984-08-09 1985-12-17 Research Corporation Rate-controlled drug release system
US4640956A (en) * 1985-06-13 1987-02-03 General Electric Company Iodine resistant silicone rubber compositions
FR2611735B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition elastomere silicone polyaddition contenant de l'iode pour le traitement de l'eau
FR2611733B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux
FR2611734B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition elastomere silicone polycondensation contenant de l'iode pour le traitement des eaux

Also Published As

Publication number Publication date
ATE71395T1 (de) 1992-01-15
ZA881325B (en) 1988-08-26
ES2027784T3 (es) 1992-06-16
JPH01217067A (ja) 1989-08-30
JPS63243164A (ja) 1988-10-11
DE3867509D1 (de) 1992-02-20
JPH0567666B2 (el) 1993-09-27
EP0285525B1 (fr) 1992-01-15
AU1211588A (en) 1988-09-01
BR8800802A (pt) 1988-10-04
AU1211488A (en) 1988-09-01
CA1310882C (fr) 1992-12-01
ZA881328B (en) 1988-08-26
EP0283407A2 (fr) 1988-09-21
GR3003746T3 (el) 1993-03-16
US4886661A (en) 1989-12-12
ES2039286T3 (es) 1993-09-16
EP0283407A3 (en) 1988-09-28
JPH0567664B2 (el) 1993-09-27
FR2611733A1 (fr) 1988-09-09
FR2611733B1 (fr) 1989-06-16
CA1308836C (fr) 1992-10-13
DE3867671D1 (de) 1992-02-27
AU601262B2 (en) 1990-09-06
ATE71646T1 (de) 1992-02-15
EP0283407B1 (fr) 1992-01-08
AU596889B2 (en) 1990-05-17
BR8800801A (pt) 1988-10-04
EP0285525A1 (fr) 1988-10-05

Similar Documents

Publication Publication Date Title
GR3003746T3 (el)
ES2005493A6 (es) Una composicion de poliorganosiloxano auto-adherente, curable.
FR2571732B1 (fr) Composition organopolysiloxanique de revetement utilisable notamment pour le traitement antiadherent et son procede d'application
DE3371091D1 (en) A process for preparing a one-component organopolysiloxane composition
LU91204I2 (fr) Pegvisomant, facultativement sous forme d'une variante de pégylation
NZ213586A (en) Polysiloxanes having terminal or pendant olefinic group(s) linked via urethane, thiourethane or urea linkage; polymerisable compositions and contact lenses
EP0464638A3 (en) Oligonucleotide analogues with terminal 3'-3' or 5'-5'-internucleotide linkages
CA2063915A1 (en) High consistency organosiloxane compositions comprising fluorinated and non-fluorinated polyorganosiloxanes
FR2429811A1 (fr) Composition de silicone durcissable a l'humidite
ATE71645T1 (de) Durch polyaddition haertbare, jod enthaltende siloxan-elastomer-zusammensetzung.
EP0283408A3 (en) Elastomeric siloxane polycondensation composition containing iodide
ES2007368A6 (es) Una composicion de poliorganosiloxano.
GB1357452A (en) Articles for biological usage which are resistant to incrustation
Lee et al. Curable Random Dimethylsiloxane/Diphenylsiloxane Copolymer Compositions
RU92007663A (ru) Слепочный стоматологический материал
FR2565110B1 (fr) Dispositif pour le traitement en cure unique d'une epidermophytose telle que le pityriasis versicolor
TW341588B (en) Composite of polysiloxane and silicone rubber and production process therefor
DE3854933D1 (de) Polynucleotid-Zusammensetzung und Verfahren zu ihrer Herstellung
JPS56129013A (en) Defoaming agent composition
Sheen Mechanism of Action of Estrogen